C9H13N3O5
243.22 g/mol
Aktif Farmasötik İngredientTehlike
Cytarabine
CAS147-94-4EC205-705-9
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Heterosiklik
Birincil Kullanım
Farmasötik ham madde
Cytarabine is a compound used in pharmaceutical manufacturing. It has been noted for potential developmental toxicity based on expert review.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 147-94-4
İlgili Bileşikler
GüçlüAynı ana yapı
CYTARABINE HYDROCHLORIDE
CAS69-74-9
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.79
2'-Fluoro-2'-deoxy-arabinofuranosyl-cytidine
CAS56632-83-8
Nucleoside analog research reagent
BenzerBenzer yapıBenzerlik 0.79
2'-Deoxy-2'-fluorocytidine
CAS10212-20-1
pharmaceutical intermediate
ReferansAynı kategori
[1-(2-Phenylethyl)-1h-imidazol-2-yl]-4-piperidinylmethanone dihydrobromide
CAS147064-11-7
Alcaftadine impurity reference standard
ReferansAynı kategori
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
CAS147082-78-8
pharmaceutical active ingredient
ReferansAynı kategori
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine
CAS147083-36-1
active pharmaceutical ingredient
ReferansAynı kategori
Alcaftadine carboxylic acid
CAS147083-93-0
Pharmaceutical active ingredient
Referansstereoisomer of
5,6-dideuterio-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-iminopyrimidin-2-one
CAS40632-25-5
deuterated research compound
Güvenlik Referansı
Tehlike
H317May cause an allergic skin reaction
H340May cause genetic defects
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
Tanımlayıcılar
IUPAC Adı
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChIKey
UHDGCWIWMRVCDJ-CCXZUQQUSA-N
SMILES
C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
Eş Anlamlılar (97)
- Citarabina [INN-Spanish]
- Cytarabine (JP18/USP/INN)
- Cytarabine, European Pharmacopoeia (EP)
- Cytarabine, United States Pharmacopeia (USP)
- Cytarabinum [INN-Latin]
- 1-Arabinofuranosylcytosine
- 1beta-D-Arabinosylcytosine
- Alexan
- Alexan 100
- Ara-C
- Ara-cell
- Arabine
- Arabinocytidine
- Arabinofuranosyl Cytidine
- Arabinofuranosylcytosine
- Arabinoside C
- Arabinoside, Cytosine
- Arabinosylcytosine
- Arabitin
- Aracytidine
- Aracytin
- Aracytine
- Arafcyt
- Beta-cytosine arabinoside
- CYTARABINE [MART.]
- Citarabina
- Cytarabin
- Cytarabina
- Cytarabine (Standard)
- Cytarabine - Bio-X trade mark
- Cytarabine CRS
- Cytarabine Impurity
- Cytarabine RS
- Cytarabinoside
- Cytarabinum
- Cytarbel
- Cytartbine
- Cytonal
- Cytosar
- Cytosar-U
- Cytosine arabinofuranoside
- Cytosine arabinose
- Cytosine arabinoside
- Cytosine arabinoside (VAN)
- Cytosine beta-D-arabinoside
- Cytosine-beta-arabinoside
- DepoCyte
- Depocyt
- Depocyt (TN)
- Depocyt (liposomal)
- Erpalfa
- Spongocytidine
- Starasid
- Tarabine
- Tarabine PFS
- U 19920A
- U-19,920
- Udicil
- VYXEOS COMPONENT CYTARABINE
- arabinocytosine
- beta Ara C
- beta-Arabinosylcytosine
- beta-D-Arabinosylcytosine
- cytarabine
- cytarabine liposome
- cytarabine liposome injection
- cytarabine ocphosphate